SEC Form 4 · accession 0001192482-18-000404
Aevi Genomic Medicine, Inc. · GNMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sol J Barer
Director
Period of report
Aug 15, 2018
Accepted (ET)
Aug 17, 2018 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001138776
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 15, 2018 | P | 2,551,020 | $0.96 | A | 2,551,020 | I | By: Barer & Son Capital LLC |
| Common Stock | holding | — | — | — | 1,028,032 | D | ||
| Common StockF2 | holding | — | — | — | 153,846 | I | By: Wife | |
| Common StockF3 | holding | — | — | — | 365,854 | I | By: Grantor Retained Annuity Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person is a member of Barer & Son Capital LLC. As a member he has an economic interest in the assets owned by Barer & Son Capital LLC; however he has no control of the investment or disposition of such assets. Nevertheless, the reported shares may be deemed beneficially owned by the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F2Shares purchased by the wife of the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F3Shares held by the Sol J. Barer 2013 Grantor Retained Annuity Trust No. IV.